How does EBO's PE Ratio compare to its peers?

EBO is good value based on its Price-To-Earnings Ratio (24.1x) compared to the peer average (48.8x).

How does EBO's PE Ratio compare vs other companies in the Global Healthcare Industry?

EBO is expensive based on its Price-To-Earnings Ratio (24.1x) compared to the Global Healthcare industry average (20.6x).

What is EBO's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

EBO is expensive based on its Price-To-Earnings Ratio (24.1x) compared to the estimated Fair Price-To-Earnings Ratio (14.6x).

What is the Fair Price of EBO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

EBO (NZ$37.22) is trading below our estimate of [[fair value]] (NZ$47.06)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Target price is less than 20% higher than the current share price.

EBOS Group (NZSE:EBO) - Stock Price, News & Analysis

EBO Stock Overview

Engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. More details

EBO fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	1/6
Past Performance	2/6
Financial Health	3/6
Dividends	4/6

Rewards

Trading at 20.9% below our estimate of its fair value

Earnings are forecast to grow 6.88% per year

Earnings have grown 13.5% per year over the past 5 years

Risk Analysis

Has a high level of debt

Dividend of 3.38% is not well covered by free cash flows

EBOS Group Limited Competitors

Summerset Group Holdings

NZSE:SUM

NZ$3.1b

Arvida Group

NZSE:ARV

NZ$1.2b

Fisher & Paykel Healthcare

NZSE:FPH

NZ$21.7b

Jointown Pharmaceutical Group

SHSE:600998

CN¥26.9b

Price History & Performance

Summary of all time highs, changes and price drops for EBOS Group
Historical stock prices
Current Share Price	NZ$37.22
52 Week High	NZ$37.99
52 Week Low	NZ$31.02
Beta	0.26
11 Month Change	1.86%
3 Month Change	3.39%
1 Year Change	5.11%
33 Year Change	3.45%
5 Year Change	63.25%
Change since IPO	1,540.12%

The Returns At EBOS Group (NZSE:EBO) Aren't Growing

Nov 11

Shareholders May Be More Conservative With EBOS Group Limited's (NZSE:EBO) CEO Compensation For Now

Oct 16

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

Oct 11

Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?

Sep 29

Recent updates

The Returns At EBOS Group (NZSE:EBO) Aren't Growing

Nov 11

Shareholders May Be More Conservative With EBOS Group Limited's (NZSE:EBO) CEO Compensation For Now

Oct 16

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

Oct 11

Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?

Sep 29

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 22% Undervalued

Sep 15

EBOS Group Limited (NZSE:EBO) Just Released Its Half-Year Earnings: Here's What Analysts Think

Feb 23

Returns At EBOS Group (NZSE:EBO) Appear To Be Weighed Down

Jan 23

EBOS Group Limited's (NZSE:EBO) Business Is Trailing The Market But Its Shares Aren't

Dec 18

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 20% Undervalued

Nov 02

Here's What To Make Of EBOS Group's (NZSE:EBO) Decelerating Rates Of Return

Oct 17

EBOS Group (NZSE:EBO) Has A Pretty Healthy Balance Sheet

Oct 02

EBOS Group's (NZSE:EBO) Upcoming Dividend Will Be Larger Than Last Year's

Aug 28

Estimating The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)

Aug 02

EBOS Group (NZSE:EBO) Is Reinvesting At Lower Rates Of Return

Jun 26

Estimating The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)

May 02

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

Apr 14

EBOS Group (NZSE:EBO) Could Be Struggling To Allocate Capital

Mar 14

EBOS Group (NZSE:EBO) Is Paying Out A Larger Dividend Than Last Year

Feb 26

A Look At The Fair Value Of EBOS Group Limited (NZSE:EBO)

Jan 06

EBOS Group (NZSE:EBO) Might Be Having Difficulty Using Its Capital Effectively

Nov 28

Here's Why EBOS Group Limited's (NZSE:EBO) CEO Compensation Is The Least Of Shareholders' Concerns

Oct 21

EBOS Group Limited (NZSE:EBO) Shares Could Be 37% Below Their Intrinsic Value Estimate

Oct 05

Does EBOS Group (NZSE:EBO) Have A Healthy Balance Sheet?

Sep 13

EBOS Group (NZSE:EBO) Will Pay A Larger Dividend Than Last Year At A$0.5116

Aug 26

Slowing Rates Of Return At EBOS Group (NZSE:EBO) Leave Little Room For Excitement

Jun 24

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 30% Undervalued

May 10

Return Trends At EBOS Group (NZSE:EBO) Aren't Appealing

Mar 17

We Think That There Are Issues Underlying EBOS Group's (NZSE:EBO) Earnings

Feb 26

EBOS Group (NZSE:EBO) Is Paying Out A Larger Dividend Than Last Year

Feb 18

EBOS Group Limited's (NZSE:EBO) Intrinsic Value Is Potentially 41% Above Its Share Price

Jan 22

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

Dec 26

EBOS Group (NZSE:EBO) Has Some Way To Go To Become A Multi-Bagger

Oct 31

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 23% Undervalued

Oct 18

Is EBOS Group (NZSE:EBO) A Risky Investment?

Sep 19

Here's Why I Think EBOS Group (NZSE:EBO) Might Deserve Your Attention Today

Aug 05

A Look At The Fair Value Of EBOS Group Limited (NZSE:EBO)

Jul 13

EBOS Group's (NZSE:EBO) Returns Have Hit A Wall

Jun 09

Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?

May 01

Here's Why EBOS Group (NZSE:EBO) Can Manage Its Debt Responsibly

Apr 08

A Look At The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)

Mar 27

Is EBOS Group Limited's (NZSE:EBO) Recent Performance Tethered To Its Attractive Financial Prospects?

Mar 15

Is EBOS Group Limited (NZSE:EBO) A Smart Pick For Income Investors?

Mar 03

Shareholder Returns

	EBO	NZ Healthcare	NZ Market
7D	0.05%	1.0%	0.1%
1Y	5.1%	9.4%	9.6%

Return vs Industry: EBO underperformed the NZ Healthcare industry which returned 9.4% over the past year.

Return vs Market: EBO underperformed the NZ Market which returned 9.6% over the past year.

Price Volatility

Is EBO's price volatile compared to industry and market?
EBO volatility
EBO Average Weekly Movement	3.4%
Healthcare Industry Average Movement	4.2%
Market Average Movement	4.5%
10% most volatile stocks in NZ Market	9.3%
10% least volatile stocks in NZ Market	3.0%

Stable Share Price: EBO has not had significant price volatility in the past 3 months compared to the NZ market.

Volatility Over Time: EBO's weekly volatility (3%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1922	4,557	John Cullity	www.ebosgroup.com

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services.

EBOS Group Limited Fundamentals Summary

How do EBOS Group's earnings and revenue compare to its market cap?
EBO fundamental statistics
Market cap	NZ$7.21b
Earnings (TTM)	NZ$301.11m
Revenue (TTM)	NZ$14.63b

24.1x

P/E Ratio

0.5x

P/S Ratio

Is EBO overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EBO income statement (TTM)
Revenue	AU$13.19b
Cost of Revenue	AU$11.56b
Gross Profit	AU$1.63b
Other Expenses	AU$1.36b
Earnings	AU$271.55m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	1.39
Gross Margin	12.38%
Net Profit Margin	2.06%
Debt/Equity Ratio	51.1%

How did EBO perform over the long term?

See historical performance and comparison

Dividends

3.4%

Current Dividend Yield

78%

Payout Ratio

EBO Stock Overview

Rewards

Risk Analysis

EBOS Group Limited Competitors

NZSE:SUM

NZ$3.1b

NZSE:ARV

NZ$1.2b

NZSE:FPH

NZ$21.7b

SHSE:600998

CN¥26.9b

Price History & Performance

Recent News & Updates

Now 21% undervalued

The Returns At EBOS Group (NZSE:EBO) Aren't Growing

EBOS Group Limited Announces the Retirement of Peter Williams as Director

Shareholders May Be More Conservative With EBOS Group Limited's (NZSE:EBO) CEO Compensation For Now

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?

Recent updates

Now 21% undervalued

The Returns At EBOS Group (NZSE:EBO) Aren't Growing

EBOS Group Limited Announces the Retirement of Peter Williams as Director

Shareholders May Be More Conservative With EBOS Group Limited's (NZSE:EBO) CEO Compensation For Now

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?

Now 20% undervalued

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 22% Undervalued

Final dividend of NZ$0.64 announced

EBOS Group Limited Announces Final Dividend, Payable on 18 September 2024

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Earnings Not Telling The Story For EBOS Group Limited (NZSE:EBO)

Are Investors Undervaluing EBOS Group Limited (NZSE:EBO) By 29%?

EBOS Group (NZSE:EBO) Is Reinvesting At Lower Rates Of Return

EBOS Group Limited Announces Chief Financial Officer Changes

EBOS Group (NZSE:EBO) Seems To Use Debt Quite Sensibly

Some Confidence Is Lacking In EBOS Group Limited's (NZSE:EBO) P/E

Insider recently sold NZ$5.3m worth of stock

EBOS Group (NZSE:EBO) Will Pay A Dividend Of A$0.5951

First half dividend of NZ$0.60 announced

EBOS Group Limited (NZSE:EBO) Just Released Its Half-Year Earnings: Here's What Analysts Think

First half 2024 earnings released: EPS: AU$0.71 (vs AU$0.70 in 1H 2023)

EBOS Group Limited to Report Fiscal Year 2024 Results on Aug 21, 2024

Now 21% undervalued

Returns At EBOS Group (NZSE:EBO) Appear To Be Weighed Down

EBOS Group Limited to Report First Half, 2024 Results on Feb 21, 2024

Now 21% undervalued

EBOS Group Limited (NZSE:EBO) acquired additional 39% stake in Transmedic Pte Ltd. from TS Lee for approximately SGD 120 million.

EBOS Group Limited's (NZSE:EBO) Business Is Trailing The Market But Its Shares Aren't

Paragon Care Reportedly Taps Rothschild for Defence Amid Buyout Talk

Now 22% undervalued after recent price drop

EBOS Reportedly Runs Eye over Paragon Care after Abandoning Greencross Pursuit

EBOS Not to Proceed with Acquisition in Animal Care Segment

EBOS Not to Proceed with Acquisition in Animal Care Segment

Now 20% undervalued

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 20% Undervalued

Here's What To Make Of EBOS Group's (NZSE:EBO) Decelerating Rates Of Return

EBOS Group (NZSE:EBO) Has A Pretty Healthy Balance Sheet

EBOS Group Limited Announces Fully Franked Ordinary Dividend for the Six Months Ended June 30, 2023, Payable on 29 September, 2023

Now 20% undervalued

Upcoming dividend of NZ$0.60 per share at 3.0% yield

EBOS Group's (NZSE:EBO) Upcoming Dividend Will Be Larger Than Last Year's

Ebos Group Limited Announces Dividend, Payable on 29 September 2023

Full year 2023 earnings: EPS misses analyst expectations

Estimating The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)

EBOS Group (NZSE:EBO) Is Reinvesting At Lower Rates Of Return

Investor sentiment deteriorates as stock falls 16%

Now 25% undervalued after recent price drop

Estimating The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

EBOS Group (NZSE:EBO) Could Be Struggling To Allocate Capital

EBOS Group (NZSE:EBO) Is Paying Out A Larger Dividend Than Last Year

First half 2023 earnings released: EPS: AU$0.70 (vs AU$0.61 in 1H 2022)

EBOS Group Limited to Report Q2, 2023 Results on Feb 22, 2023

A Look At The Fair Value Of EBOS Group Limited (NZSE:EBO)

EBOS Group (NZSE:EBO) Might Be Having Difficulty Using Its Capital Effectively

Here's Why EBOS Group Limited's (NZSE:EBO) CEO Compensation Is The Least Of Shareholders' Concerns

EBOS Group Limited (NZSE:EBO) Shares Could Be 37% Below Their Intrinsic Value Estimate

EBOS Group Limited Announces the Appointment of Mark Bloom as an Independent Director, Effective 16 September 2022